BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Treatment
229 results:

  • 1. The radiological characteristics, tertiary lymphoid structures, and survival status associated with EGFR mutation in patients with subsolid nodules like stage I-II LUAD.
    Xie M; Gao J; Ma X; Song J; Wu C; Zhou Y; Jiang T; Liang Y; Yang C; Bao X; Zhang X; Yao J; Jing Y; Wu J; Wang J; Xue X
    BMC Cancer; 2024 Mar; 24(1):372. PubMed ID: 38528507
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. XAF1 overexpression inhibits the malignant progression and cisplatin resistance of NSCLC by activating endoplasmic reticulum stress.
    Chen B; Cheng Y; Wu H; Yao J
    Mol Biol Rep; 2024 Mar; 51(1):435. PubMed ID: 38520543
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy.
    Petroni G; Pillozzi S; Antonuzzo L
    Cancer Res; 2024 Apr; 84(8):1199-1209. PubMed ID: 38381540
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immunotherapy for non-small cell lung cancer.
    Kagamu H
    Respir Investig; 2024 Mar; 62(2):307-312. PubMed ID: 38310751
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma.
    Wang D; Huang L; Qian D; Cao Y; Wu X; Xu P; Ming L; Tang J; Huang Z; Yin Y; Zhou L
    Front Immunol; 2023; 14():1334408. PubMed ID: 38259481
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Afatinib-Induced Tumor Lysis Syndrome in Pulmonary Adenocarcinoma: A Case Report and Literature Review.
    Hong G
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138247
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Repositioning of mifepristone as an integrated stress response activator to potentiate cisplatin efficacy in non-small cell lung cancer.
    Namkaew J; Zhang J; Yamakawa N; Hamada Y; Tsugawa K; Oyadomari M; Miyake M; Katagiri T; Oyadomari S
    Cancer Lett; 2024 Feb; 582():216509. PubMed ID: 38036042
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Current diagnosis and treatment of salivary gland-type tumors of the lung.
    Horio Y; Kuroda H; Masago K; Matsushita H; Sasaki E; Fujiwara Y
    Jpn J Clin Oncol; 2024 Mar; 54(3):229-247. PubMed ID: 38018262
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Proton therapy (PT) combined with concurrent chemotherapy for locally advanced non-small cell lung cancer with negative driver genes.
    Jin Y; Shimizu S; Li Y; Yao Y; Liu X; Si H; Sakurai H; Xiao W
    Radiat Oncol; 2023 Nov; 18(1):189. PubMed ID: 37974211
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Synergistic anticancer activity of cisplatin combined with tannic acid enhances apoptosis in lung cancer through the PERK-ATF4 pathway.
    Zheng X; Yang L; Zhai W; Geng N; Zhang Z; Li X; Wu M
    Eur J Med Res; 2023 Oct; 28(1):462. PubMed ID: 37885044
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Recent Progress of Tertiary Lymphoid Structure in Prognosis and Immunotherapy of Non-small Cell lung cancer].
    Liu Y; Xiong L; Cai R; Chen Y; Ye J; Shen B; Zhou G
    Zhongguo Fei Ai Za Zhi; 2023 Aug; 26(8):615-620. PubMed ID: 37752541
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Cordycepin, a metabolite of
    Zheng Q; Shao Y; Zheng W; Zou Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):873-878. PubMed ID: 37439158
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy.
    Yin X; Wang H; Li R; Song X; Zhang T; Liang Y; Chen YZ; Yu X; Mao Q; Xia W; Chen B; Xu L; Dong G; Jiang F
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37369391
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis.
    Liu C; Zhang X; Zhu Y; Wei J; Ye X; Yang C; Tong H; Mai W; Yang M; Qian J; Mao L; Meng H; Jin J; Yu W
    Ann Hematol; 2023 Sep; 102(9):2387-2395. PubMed ID: 37278748
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Marsdenia tenacissima extract induces endoplasmic reticulum stress-associated immunogenic cell death in non-small cell lung cancer cells through targeting AXL.
    Yuan Y; Guo Y; Guo ZW; Hao HF; Jiao YN; Deng XX; Han SY
    J Ethnopharmacol; 2023 Oct; 314():116620. PubMed ID: 37207882
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell lung cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum-Etoposide Chemotherapy.
    Morimoto K; Yamada T; Takeda T; Shiotsu S; Date K; Harada T; Tamiya N; Chihara Y; Takemura Y; Yamada T; Kanda H; Ishida M; Yoshimura A; Iwasaku M; Tokuda S; Kim YH; Takayama K
    Drugs Aging; 2023 Jun; 40(6):563-571. PubMed ID: 37145245
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer.
    Sandström Gerdtsson A; Knulst M; Botling J; Mezheyeuski A; Micke P; Ek S
    Oncoimmunology; 2023; 12(1):2206725. PubMed ID: 37139184
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Nimbolide Exhibits Potent Anticancer Activity Through ROS-Mediated ER Stress and DNA Damage in Human Non-small Cell lung cancer Cells.
    Chen X; Zhang H; Pan Y; Zhu N; Zhou L; Chen G; Wang J
    Appl Biochem Biotechnol; 2024 Jan; 196(1):182-202. PubMed ID: 37103738
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
    Ng KW; Boumelha J; Enfield KSS; Almagro J; Cha H; Pich O; Karasaki T; Moore DA; Salgado R; Sivakumar M; Young G; Molina-Arcas M; de Carné Trécesson S; Anastasiou P; Fendler A; Au L; Shepherd STC; Martínez-Ruiz C; Puttick C; Black JRM; Watkins TBK; Kim H; Shim S; Faulkner N; Attig J; Veeriah S; Magno N; Ward S; Frankell AM; Al Bakir M; Lim EL; Hill MS; Wilson GA; Cook DE; Birkbak NJ; Behrens A; Yousaf N; Popat S; Hackshaw A; ; ; Hiley CT; Litchfield K; McGranahan N; Jamal-Hanjani M; Larkin J; Lee SH; Turajlic S; Swanton C; Downward J; Kassiotis G
    Nature; 2023 Apr; 616(7957):563-573. PubMed ID: 37046094
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.